CQDM welcomes two additional Pharma members, Boehringer Ingelheim and GlaxoSmithKline Inc.
Related news
Our News
CQDM and Epitopea Fund the Development and Validation of CryptoMapTM a Supportive Platform Enabling the Development of RNA-based Immunotherapies
Our News
GlycoNet and CQDM collaborate to boost drug discovery and develop new health solutions for Canadians
Events
Our News
4th edition of Sweet Biopharma Day – Call for entries now open